White Glo Charcoal Sensitive
Potassium Nitrate, Sodium Monofluorophosphate
White Glo Usa Inc
Human Otc Drug
NDC 73656-011White Glo Charcoal Sensitive also known as Potassium Nitrate, Sodium Monofluorophosphate is a human otc drug labeled by 'White Glo Usa Inc'. National Drug Code (NDC) number for White Glo Charcoal Sensitive is 73656-011. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in White Glo Charcoal Sensitive drug includes . The currest status of White Glo Charcoal Sensitive drug is Active.
Drug Information:
| Drug NDC: | 73656-011 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | White Glo Charcoal Sensitive |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Potassium Nitrate, Sodium Monofluorophosphate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | White Glo Usa Inc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Kit |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 16 Mar, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part356 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | WHITE GLO USA INC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0879226000954
|
| UPC stands for Universal Product Code. |
| UNII: | |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73656-011-00 | 1 KIT in 1 KIT (73656-011-00) * 1 BOX in 1 TUBE (73656-012-00) / 150 g in 1 BOX | 16 Mar, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antihypersensitivity anticavity
Product Elements:
White glo charcoal sensitive potassium nitrate, sodium monofluorophosphate white glo charcoal sensitive potassium nitrate, sodium monofluorophosphate sorbitol hydrated silica sodium lauryl sulfate glycerin water carboxymethylcellulose sodium, unspecified form chondrus crispus carrageenan saccharin sodium sodium benzoate activated charcoal potassium nitrate nitrate ion sodium monofluorophosphate fluoride ion
Indications and Usage:
Uses ⢠builds increasing protection against: painful sensitivity of the teeth to cold, heat, acids, sweets or contact. ⢠aids in the prevention of dental cavities.
Warnings:
Warnings when using this product, if irritation occurs discontinue use. stop use and ask a dentist if ⢠the problem persists or worsens. sensitive teeth may indicate a serious problem that may need prompt care by a dentist. ⢠pain/sensitivity still persists after 4 weeks of use. keep out of reach of children. if more than used for brushing is accidentally swallowed, get medical help or contact a poison control center right away.
When Using:
When using this product, if irritation occurs discontinue use.
Dosage and Administration:
Directions ⢠adults and children 12 years of age and older: ⢠apply at least a 1-inch strip of the product onto a soft bristle toothbrush. ⢠brush teeth thoroughly for at least 1 minute twice a day (morning and evening), and not more than 3 times a day, or as recommended by dentist or doctor. make sure to brush all sensitive areas of the teeth. minimize swallowing. spit out after brushing. ⢠children under 12 years of age: consult a dentist or doctor.
Stop Use:
Stop use and ask a dentist if ⢠the problem persists or worsens. sensitive teeth may indicate a serious problem that may need prompt care by a dentist. ⢠pain/sensitivity still persists after 4 weeks of use.
Package Label Principal Display Panel:
Package labeling: label
Further Questions:
Questions or comments? for customer enquiries, please contact: customer.enquiry@whiteglo.com white glo usa inc. 25 suffolk court, hauppauge, ny, 11788 usa. www.whiteglo.com